About Us

BioLab Assays Ltd. is a dynamic life-science company that develops, manufactures, and sells innovative and original ready-to-use ELISA (enzyme-linked immunosorbent assay) kits. Our portfolio includes solid phase 96-well ELISA designed for quantitative measurement of cytokines, acute reactant proteins or chemokines, and optimized for serum, plasma, urine, saliva, or CSF samples. Our products cover the following clinical topics: obesity, IR, metabolic syndrome, diabetes mellitus, kidney disorders, pulmonary disorders, animal care and studies, bone metabolism, inflammation, and infection.

QMS Quality Manual

Quality Policy

„We fulfill our mission to enable our customers to make the reserarch more targeted, accurate and perspicuous by continuously improving the quality of our products and services and by ensuring global regulatory compliance.“

News

KREBS VON DER LUNGEN-6 (KL-6): PROVEN MARKER OF INTERSTITIAL LUNG DISEASE

30. 11. 2023

BACKGROUND Krebs von den Lungen-6 (KL-6) is a high-molecular mucin-like glycoprotein, encoded by MUC1 gene. KL-6/MUC1 regulates cell-cell...

Monomeric CRP: A KEY MOLECULE DRIVING DEVELOPMENT OF ALZHEIMER’S DISEASE?

26. 03. 2023

BACKGROUND C-reactive protein (CRP) is a multipotent protein that undergoes conformational changes between circulating native pentameric...

Monomeric CRP: A NEW PLAYER IN EVALUATION OF CARDIOVASCULAR RISK?

26. 03. 2023

BACKGROUND: CRP AND MONOMERIC CRP (mCRP) IN INFLAMMATION Although CRP is an independent risk factor for CVD and offers a prognostic...

© 2024 All rights reserved.